In-practice Evaluation of Atacand 16mg Antihypertensive Effect

In-practice Evaluation of Atacand 16mg Antihypertensive Effect

The purpose of this study is to prove in practice the effectiveness of Atacand 16 mg in reducing blood pressure after 4 weeks of administration and the importance of administration of adequate doses

Inclusion Criteria:

• Adult patients with mild (140-159/90-99 mgHg) to moderate (160-179/100-109 mmHg) essential hypertension, already treated with Atacand 8mg for 2-4 weeks, who have not reached the blood pressure treatment goal at least <140/90 mgHg and the doctor has decided
• Signed and dated Patient Informed Consent (ICF)

Exclusion Criteria:

• Hypersensitivity to the active substance or to any of the excipients of Atacand.